Market Closed -
Bombay S.E.
06:13:58 2024-05-06 am EDT
|
5-day change
|
1st Jan Change
|
163.8
INR
|
-1.44%
|
|
-4.88%
|
+1.83%
|
Fiscal Period: March |
2019
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
10,212
|
31,903
|
74,319
|
-
|
Enterprise Value (EV)
1 |
10,212
|
31,903
|
74,319
|
74,319
|
P/E ratio
|
13.3
x
|
11
x
|
22.3
x
|
18.3
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.02
x
|
-
|
3.44
x
|
2.82
x
|
EV / Revenue
|
1.02
x
|
-
|
3.44
x
|
2.82
x
|
EV / EBITDA
|
7.47
x
|
-
|
14.2
x
|
11.8
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
3.58
x
|
2.99
x
|
Nbr of stocks (in thousands)
|
409,314
|
453,164
|
453,164
|
-
|
Reference price
2 |
24.95
|
70.40
|
164.0
|
164.0
|
Announcement Date
|
5/29/19
|
5/30/23
|
-
|
-
|
Fiscal Period: March |
2019
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
10,001
|
-
|
21,583
|
26,332
|
EBITDA
1 |
1,368
|
-
|
5,229
|
6,305
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
4,490
|
5,468
|
Net income
1 |
804.4
|
2,653
|
3,335
|
4,066
|
Net margin
|
8.04%
|
-
|
15.45%
|
15.44%
|
EPS
2 |
1.870
|
6.410
|
7.360
|
8.970
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/29/19
|
5/30/23
|
-
|
-
|
Fiscal Period: March |
2024 Q3
|
---|
Net sales
1 |
5,525
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
1 |
1,179
|
Net income
1 |
865
|
Net margin
|
15.66%
|
EPS
2 |
1.910
|
Dividend per Share
|
-
|
Announcement Date
|
-
|
Fiscal Period: March |
2019
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
15.9%
|
-
|
16%
|
16%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
45.90
|
54.80
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/29/19
|
5/30/23
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +28.50% | 662B | | +22.23% | 546B | | -4.93% | 359B | | +16.97% | 323B | | +4.08% | 289B | | +13.68% | 234B | | +3.84% | 198B | | -10.35% | 194B | | +3.98% | 167B |
Other Pharmaceuticals
|